Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Perceptions of DoxyPEP use Among Racial & Ethnic Minority Patients.

Created on 10 Oct 2026

Authors

Dennis Rivera-Cash, Alo Rodriguez, Ankshita Dasgupta, Juan Rivera, Aniruddha Hazra, Jade Pagkas-Bather, Jose I Gutierrez, Moira C McNulty, Maria Pyra

Published in

Journal of racial and ethnic health disparities. Oct 09, 2026. Epub Oct 09, 2026.

Abstract

To maximize the impact of doxycycline post-exposure prophylaxis (doxyPEP) in controlling the bacterial STI epidemic, understanding of the barriers to delivering doxyPEP to the most vulnerable populations is essential. Guided by the COM-B (capability, opportunity, motivation, and behavior) framework, we interviewed 26 racial and ethnically diverse participants eligible for doxyPEP to identify barriers and facilitators to doxyPEP use. Participants reported facilitators such as: knowledge; positive clinical encounters; community normalization; and beliefs regarding efficacy, peer attitudes and motivations around doxyPEP. Barriers included confusion with HIV PrEP and a need for more knowledge; access to healthcare or negative experiences with healthcare; limited community awareness and concerns around disclosure. However, participants also described potential solutions, including specific knowledge needed, low barrier and non-judgmental healthcare, home STI testing, and increased community awareness and normalization.

PMID:
42855654
Bibliographic data and abstract were imported from PubMed on 10 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 4
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement